Transcript Slide 1

Reimbursement in EU/USA for
Pharmaceuticals and Medical Devices
A Step By Step Checklist
Amir Inbar, CEO
Mediclever Reimbursement Consultants
[email protected]
www.mediclever.com
UK Office:
• 27 Old Gloucester St.,
London WC1N 3AX
• [email protected]
/241
1 / •9 +44.208.099.7435
US Office:
Israel Office:
• 616 Corporate Way, Suite 2-4683,
• 3b Lubetkin St.,
Herzliya 4640903
Valley Cottage, NY 10989
• [email protected][email protected]
• +972.50.837.1711
• +1.845.570.2910 Copyright © 2014 Mediclever
Ltd.
Checklist
1. Reimbursement
Landscape:
a. Seek existing/
relevant
reimbursement
mechanisms
b. Define Decision
Makers
c. Formulate initial
reimbursement
strategy
More Info / Pricing
Timing
Costs
Clients
In order to define the existing reimbursement scenario for a new product (drug
or device), we start with the Reimbursement Landscape Report.
In the Reimbursement Landscape Report we:
• Analyze the relevant market/s, providing numbers of currently conducted
procedures, type of Payers (insurance companies) that finance them and
overall spending.
• Find out whether there are any existing codes, coverage policies and
payment mechanisms that could be utilized or compared to, the new
medical product.
• Define the most relevant Decision Makers for the reimbursement of the new
medical product.
• Formulate an initial reimbursement strategy for the new medical product.
2/9
Copyright © 2014 Mediclever Ltd.
Checklist
1. Reimbursement
Landscape:
Costs
2. Evidence
Planning:
a. Seek existing/
relevant
reimbursement
mechanisms
a. Value Story
b. Define Decision
Makers
c. Study Protocol
c. Formulate initial
reimbursement
strategy
More Info / Pricing
3/9
Timing
b. Economic
Model
d. Stake-holders’
feedback
Clients
Before the company initiates any clinical studies, we
carefully plan the required ‘evidence’ for the
reimbursement of the new medical product:
a. Value Story: Lays out the clinical AND economic
benefits of using the new medical product, from the
identified Decision Makers’ perspective.
b. Economic Model: Quantifies the economic benefit,
allows for sensitivity analysis and later on, used as a
sales tool.
c. Reimbursement Related Parameters: Integrated in
the clinical study protocol.
More Info / Pricing
d. Stakeholders’ Feedback: Verifies, in advance, the
willingness of the actual Decision Makers to finance
the use of the new medical product if the claims in
the Value Story are proven according to the
presented clinical study protocol.
Copyright © 2014 Mediclever Ltd.
Checklist
1. Reimbursement
Landscape:
Timing
Costs
2. Evidence
Planning:
a. Seek existing/
relevant
reimbursement
mechanisms
a. Value Story
b. Define Decision
Makers
c. Study Protocol
c. Formulate initial
reimbursement
strategy
More Info / Pricing
b. Economic
Model
d. Stake-holders’
feedback
Clients
3. Generate
Evidence:
a. Perform
study (if
needed)
b. Publish
data
c. Dossier
More Info / Pricing
• Now, the clinical study may be conducted (if needed).
• The resulting ‘evidence’, substantiating the claims in the Value Story, should
be published
• Compile Value Story, Economic Model, and published clinical data to a dossier
4/9
Copyright © 2014 Mediclever Ltd.
Checklist
1. Reimbursement
Landscape:
Timing
Costs
2. Evidence
Planning:
a. Seek existing/
relevant
reimbursement
mechanisms
a. Value Story
b. Define Decision
Makers
c. Study Protocol
c. Formulate initial
reimbursement
strategy
More Info / Pricing
b. Economic
Model
d. Stake-holders’
feedback
Clients
3. Generate
Evidence:
a. Perform
study (if
needed)
b. Publish
data
c. Dossier
4. Implementation
Use this dossier to:
a. Establish an initial
user base
b. Harness local medical
community’s support
c. Utilize intermediate
reimbursement
mechanisms
d. If needed, develop
new mechanisms
More Info / Pricing
• The developed dossier is used to facilitate the conditions for
intermediate and long-term reimbursement applications.
5/9
Copyright © 2014 Mediclever Ltd.
More Info / Pricing
Checklist
Timing
Costs
Clients
Start early! The outcome of this Reimbursement
Landscape report could impact product development,
relevant applications and the targeted markets
1. Reimbursement
Landscape:
2. Evidence
Planning:
a. Seek existing/
relevant
reimbursement
mechanisms
a. Value Story
b. Define Decision
Makers
c. Study Protocol
c. Formulate initial
reimbursement
strategy
More Info / Pricing
b. Economic
Model
d. Stake-holders’
feedback
3. Generate
Evidence:
a. Perform
study (if
needed)
b. Publish
data
c. Dossier
More Info / Pricing
Prior to finalizing first clinical study protocol
6/9
Copyright © 2014 Mediclever Ltd.
4. Implementation
Use this dossier to:
a. Establish an initial
user base
b. Harness local medical
community’s support
c. Utilize intermediate
reimbursement
mechanisms
d. If needed, develop
new mechanisms
More Info / Pricing
Checklist
Timing
Costs
Clients
To receive our quote, kindly click on the appropriate “More Info /
Pricing” link in one of the relevant boxes below.
1. Reimbursement
Landscape:
a. Seek existing/
relevant
reimbursement
mechanisms
a. Value Story
b. Define Decision
Makers
c. Study Protocol
c. Formulate initial
reimbursement
strategy
More Info / Pricing
7/9
2. Evidence
Planning:
b. Economic
Model
d. Stake-holders’
feedback
3. Generate
Evidence:
a. Perform
study (if
needed)
b. Publish
data
c. Dossier
More Info / Pricing
Copyright © 2014 Mediclever Ltd.
4. Implementation
Use this dossier to:
a. Establish an initial
user base
b. Harness local medical
community’s support
c. Utilize intermediate
reimbursement
mechanisms
d. If needed, develop
new mechanisms
More Info / Pricing
Checklist
8/9
Timing
Costs
Clients
Copyright © 2014 Mediclever Ltd.
Checklist
Timing
Costs
Clients
Thank You For Your Attention
UK Office:
• 27 Old Gloucester St.,
London WC1N 3AX
• [email protected]
• +44.208.099.7435
9/9
Amir Inbar, CEO
http://www.mediclever.com
[email protected]
http://twitter.com/mediclever
+44.208.099.7435
http://mediclever.com/blog
US Office:
• 616 Corporate Way, Suite 2-4683,
Valley Cottage, NY 10989
• [email protected]
• +1.845.570.2910
Israel Office:
• 3b Lubetkin St.,
Herzliya 4640903
• [email protected]
• +972.50.837.1711
Copyright © 2014 Mediclever Ltd.